The 7th Emirates Multiple Sclerosis Forum 2025 convened leading neurologists, researchers, and allied health professionals for a critical examination of the evolving paradigms in MS diagnosis, monitoring, and treatment. This specialized forum provided a dynamic platform to translate cutting-edge research and biomarker science into actionable strategies for personalized patient management.
The day commenced with focused, interactive workshops designed to enhance clinical precision. Workshop 1 delved into "Radiological Biomarkers in MS," providing a deep dive into interpreting key MRI features in the context of the 2017 McDonald Criteria and assessing treatment response. Workshop 2 equipped attendees with practical skills in the application of "Clinical Scales in MS Care," focusing on the accurate use of tools like the EDSS and MSFC to monitor disability and disease progression in routine practice.
The main scientific sessions featured robust discussions on optimizing therapeutic pathways. A pivotal discussion on "RISC and Smoldering MS" explored risk stratification and early intervention strategies for insidious disease activity. The forum placed significant emphasis on advanced biomarker utility, with dedicated sessions examining the role of Neurofilament Light Chain (NfL) as a reliable guide for treatment decisions and monitoring. The agenda also highlighted the practical implementation of treat-to- target strategies and the "Pillars of Effective MS Management," moving beyond simple disease suppression to encompass holistic, long-term patient outcomes.
Further enriching the dialogue, sessions addressed complex symptom management, including targeted approaches to optic neuritis and myelopathy. The forum also provided valuable insights into real-world clinical experiences, featuring perspectives on treatment sequencing, managing transitions to high-efficacy therapies, and leveraging over a decade of transformational data with specific disease-modifying treatments.
By integrating hands-on workshop training with high-level scientific exchange on biomarkers, treatment strategies, and complex care, the 7th Emirates MS Forum successfully equipped clinicians with the advanced tools and knowledge necessary to navigate the modern, precision-based landscape of multiple sclerosis care.
